↓ Skip to main content

Dove Medical Press

Article Metrics

Role of eslicarbazepine in the treatment of epilepsy in adult patients with partial-onset seizures

Overview of attention for article published in Therapeutics and Clinical Risk Management, March 2010
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
18 Mendeley
Title
Role of eslicarbazepine in the treatment of epilepsy in adult patients with partial-onset seizures
Published in
Therapeutics and Clinical Risk Management, March 2010
DOI 10.2147/tcrm.s6382
Pubmed ID
Authors

Rifaat El-Mallakh

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Argentina 1 6%
Unknown 17 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 22%
Student > Doctoral Student 3 17%
Other 2 11%
Lecturer > Senior Lecturer 2 11%
Professor 1 6%
Other 4 22%
Unknown 2 11%
Readers by discipline Count As %
Medicine and Dentistry 9 50%
Agricultural and Biological Sciences 4 22%
Business, Management and Accounting 1 6%
Economics, Econometrics and Finance 1 6%
Neuroscience 1 6%
Other 0 0%
Unknown 2 11%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 September 2017.
All research outputs
#3,299,285
of 11,700,978 outputs
Outputs from Therapeutics and Clinical Risk Management
#204
of 857 outputs
Outputs of similar age
#92,483
of 251,897 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#5
of 20 outputs
Altmetric has tracked 11,700,978 research outputs across all sources so far. This one is in the 49th percentile – i.e., 49% of other outputs scored the same or lower than it.
So far Altmetric has tracked 857 research outputs from this source. They receive a mean Attention Score of 4.1. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 251,897 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.